Medistim ASA (OSL:MEDI)
Norway
· Delayed Price · Currency is NOK 210.00
+2.00 (0.95%)
May 13, 2025, 4:25 PM CET
Medistim ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 3,832 | 2,738 | 3,912 | 4,216 | 6,693 | 4,550 | Upgrade
|
| Market Cap Growth | -6.50% | -30.01% | -7.22% | -37.01% | 47.10% | 30.29% | Upgrade
|
| Enterprise Value | 3,675 | 2,618 | 3,790 | 4,111 | 6,629 | 4,475 | Upgrade
|
| Last Close Price | 210.00 | 144.18 | 201.40 | 214.03 | 335.63 | 225.71 | Upgrade
|
| PE Ratio | 31.19 | 26.37 | 37.68 | 36.99 | 73.64 | 65.58 | Upgrade
|
| Forward PE | 36.10 | 25.34 | 33.80 | 39.94 | 61.56 | 55.62 | Upgrade
|
| PS Ratio | 6.35 | 4.92 | 7.51 | 8.67 | 16.02 | 12.77 | Upgrade
|
| PB Ratio | 8.22 | 6.27 | 9.83 | 11.47 | 21.87 | 17.72 | Upgrade
|
| P/TBV Ratio | 9.80 | 7.26 | 11.10 | 12.71 | 24.26 | 20.30 | Upgrade
|
| P/FCF Ratio | 28.65 | 19.98 | 38.05 | 40.45 | 55.79 | 68.24 | Upgrade
|
| P/OCF Ratio | 27.41 | 19.13 | 32.82 | 37.15 | 52.55 | 61.38 | Upgrade
|
| EV/Sales Ratio | 6.08 | 4.71 | 7.27 | 8.45 | 15.87 | 12.56 | Upgrade
|
| EV/EBITDA Ratio | 20.21 | 17.84 | 25.83 | 26.11 | 52.09 | 42.60 | Upgrade
|
| EV/EBIT Ratio | 23.23 | 19.97 | 28.83 | 29.10 | 59.73 | 46.87 | Upgrade
|
| EV/FCF Ratio | 27.48 | 19.11 | 36.86 | 39.43 | 55.26 | 67.11 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.08 | 0.04 | 0.05 | 0.08 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.14 | 0.22 | 0.11 | 0.10 | 0.18 | 0.35 | Upgrade
|
| Debt / FCF Ratio | 0.20 | 0.25 | 0.17 | 0.16 | 0.20 | 0.59 | Upgrade
|
| Asset Turnover | 1.05 | 1.03 | 1.05 | 1.10 | 1.12 | 1.05 | Upgrade
|
| Inventory Turnover | 0.73 | 0.74 | 0.87 | 1.01 | 0.93 | 0.76 | Upgrade
|
| Quick Ratio | 2.52 | 2.41 | 2.53 | 2.64 | 2.62 | 2.23 | Upgrade
|
| Current Ratio | 3.91 | 4.00 | 4.15 | 3.87 | 3.95 | 4.13 | Upgrade
|
| Return on Equity (ROE) | 27.42% | 24.88% | 27.12% | 33.83% | 32.30% | 28.11% | Upgrade
|
| Return on Assets (ROA) | 17.26% | 15.16% | 16.62% | 19.93% | 18.52% | 17.50% | Upgrade
|
| Return on Capital (ROIC) | 21.22% | 18.48% | 20.53% | 24.69% | 22.16% | 20.97% | Upgrade
|
| Return on Capital Employed (ROCE) | 31.80% | 28.00% | 31.90% | 36.90% | 34.10% | 33.30% | Upgrade
|
| Earnings Yield | 3.21% | 3.79% | 2.65% | 2.70% | 1.36% | 1.52% | Upgrade
|
| FCF Yield | 3.49% | 5.00% | 2.63% | 2.47% | 1.79% | 1.47% | Upgrade
|
| Dividend Yield | 2.86% | 4.16% | 2.23% | 2.10% | 1.12% | 1.33% | Upgrade
|
| Payout Ratio | 67.07% | 79.37% | 79.15% | 60.01% | 60.11% | 72.14% | Upgrade
|
| Buyback Yield / Dilution | - | -0.10% | -0.10% | -0.15% | -0.07% | -0.13% | Upgrade
|
| Total Shareholder Return | 2.86% | 4.06% | 2.13% | 1.95% | 1.05% | 1.20% | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.